KORU Medical Systems, Inc. (KRMD)

Market Cap	166.45M
Revenue (ttm)	31.99M
Net Income (ttm)	-11.97M
Shares Out	45.86M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,607
Open	3.660
Previous Close	3.650
Day's Range	3.495 - 3.660
52-Week Range	1.978 - 3.690
Beta	0.41
Analysts	Strong Buy
Price Target	4.13 (+13.77%)
Earnings Date	Nov 13, 2024

About KRMD

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The comp...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 82
• Stock Exchange: NASDAQ
• Ticker Symbol: KRMD
• Website: https://www.korumedical.com

Financial Performance

In 2023, KORU Medical Systems's revenue was $28.52 million, an increase of 2.23% compared to the previous year's $27.90 million. Losses were -$13.74 million, 58.7% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price forecast is $4.13, which is an increase of 13.77% from the latest price.

Price Target

$4.13

(13.77% upside)

Analyst Consensus: Strong Buy